Despite progress involving the use of induced pluripotent stem cells (iPSCs) within disease modeling and drug discovery applications, it will be a long path to achieve the broad-scale use of iPSC-derived cell types for use in human patients. Within a preclinical context, cell types differentiated from iPSCs are tested for their therapeutic response by using animal models. Then, clinical trials are conducted to assure that essential parameters, such as tumorigenicity, dose toxicity, and immunogenicity, are assessed before authorizing the product for use in human patients. [Read more…]
Induced Pluripotent Stem Cell Clinical Trials, by Disease and Country
A number of induced pluripotent stem cell (iPSC) derived disease models have resulted in the discovery of new drugs that have been tested in iPSC-derived cells for efficacy and potential toxicities. Genome editing technologies have also added a new dimension to to the development of personalized medicine using iPSCs. In some cases, iPSC-derived cell types are being explored as novel cell therapeutics. [Read more…]
TreeFrog Therapeutics Awarded the Galien MedStartup Prize for its International Consortium on iPSC Quality with US, Japan & France
-
The Prix Galien MedStartup was awarded on October 26th in Boston to the French cell therapy biotech TreeFrog Therapeutics in the category “Biopharmaceutical Industry”
-
Organized by the prestigious Galien Foundation and Business France, the Prix Galien MedStartup rewards the best Franco-American collaborations in the pharmaceutical sector.
-
TreeFrog Therapeutics received this award for the QC-Stem International Consortium, which brings together world-class experts in induced pluripotent stem cell (iPSC) quality from the Harvard Stem Cell Institute and the Dana-Farber Cancer Institute in Boston (USA), the FBRI in Kobe (Japan) and the Imagine Institute in Paris (France).
Stem Cell Transplants: What To Know About This Life-Saving Procedure
Stem cell transplants are a medical procedure in which which stem cells are transplanted into an injured or diseased recipient. This procedure can either involve stem cells derived from one’s self or stem cells derived from a healthy donor.
In this article:
Ronawk Offering Free Samples of T-Blocks to Slash Stem Cell Expansion Costs & Labor Hours
OLATHE, Kansas — Ronawk, innovators in stem cell expansion technologies, has launched a trial program to provide its patented tissue-blocks (T-Blocks) to commercial cell producers and regenerative medicine partners. Their T-Blocks are a 3D matrix consumable product that enable the stem cell industry by providing means to increase stem cell production by 3,600 times vs. traditional expansion methods. [Read more…]
- « Previous Page
- 1
- …
- 95
- 96
- 97
- 98
- 99
- …
- 202
- Next Page »